Literature DB >> 30174241

Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity.

Christopher Dravis1, Chi-Yeh Chung2, Nikki K Lytle3, Jaslem Herrera-Valdez2, Gidsela Luna2, Christy L Trejo2, Tannishtha Reya3, Geoffrey M Wahl4.   

Abstract

Cell state reprogramming during tumor progression complicates accurate diagnosis, compromises therapeutic effectiveness, and fuels metastatic dissemination. We used chromatin accessibility assays and transcriptional profiling during mammary development as an agnostic approach to identify factors that mediate cancer cell state interconversions. We show that fetal and adult basal cells share epigenetic features consistent with multi-lineage differentiation potential. We find that DNA-binding motifs for SOX transcription factors are enriched in chromatin that is accessible in stem/progenitor cells and inaccessible in differentiated cells. In both mouse and human tumors, SOX10 expression correlates with stem/progenitor identity, dedifferentiation, and invasive characteristics. Strikingly, we demonstrate that SOX10 binds to genes that regulate neural crest cell identity, and that SOX10-positive tumor cells exhibit neural crest cell features.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  breast cancer; cancer stem cells; cell state plasticity; intra-tumoral heterogeneity; mammary gland development; mammary stem cells; metastasis; neural crest cells; triple-negative breast cancer

Mesh:

Substances:

Year:  2018        PMID: 30174241      PMCID: PMC6152943          DOI: 10.1016/j.ccell.2018.08.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  62 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Distinct stem cells contribute to mammary gland development and maintenance.

Authors:  Alexandra Van Keymeulen; Ana Sofia Rocha; Marielle Ousset; Benjamin Beck; Gaëlle Bouvencourt; Jason Rock; Neha Sharma; Sophie Dekoninck; Cédric Blanpain
Journal:  Nature       Date:  2011-10-09       Impact factor: 49.962

3.  Analysis of Normal Human Mammary Epigenomes Reveals Cell-Specific Active Enhancer States and Associated Transcription Factor Networks.

Authors:  Davide Pellacani; Misha Bilenky; Nagarajan Kannan; Alireza Heravi-Moussavi; David J H F Knapp; Sitanshu Gakkhar; Michelle Moksa; Annaick Carles; Richard Moore; Andrew J Mungall; Marco A Marra; Steven J M Jones; Samuel Aparicio; Martin Hirst; Connie J Eaves
Journal:  Cell Rep       Date:  2016-11-15       Impact factor: 9.423

Review 4.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

5.  Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells.

Authors:  Christopher Dravis; Benjamin T Spike; J Chuck Harrell; Claire Johns; Christy L Trejo; E Michelle Southard-Smith; Charles M Perou; Geoffrey M Wahl
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

6.  Multipotent luminal mammary cancer stem cells model tumor heterogeneity.

Authors:  Lei Bao; Robert D Cardiff; Paul Steinbach; Karen S Messer; Lesley G Ellies
Journal:  Breast Cancer Res       Date:  2015-10-14       Impact factor: 6.466

7.  A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63.

Authors:  Xiaomin Bao; Adam J Rubin; Kun Qu; Jiajing Zhang; Paul G Giresi; Howard Y Chang; Paul A Khavari
Journal:  Genome Biol       Date:  2015-12-18       Impact factor: 13.583

8.  deepTools: a flexible platform for exploring deep-sequencing data.

Authors:  Fidel Ramírez; Friederike Dündar; Sarah Diehl; Björn A Grüning; Thomas Manke
Journal:  Nucleic Acids Res       Date:  2014-05-05       Impact factor: 16.971

Review 9.  Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity.

Authors:  Elanor N Wainwright; Paola Scaffidi
Journal:  Trends Cancer       Date:  2017-05-05

10.  ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors.

Authors:  Christian Schmidl; André F Rendeiro; Nathan C Sheffield; Christoph Bock
Journal:  Nat Methods       Date:  2015-08-17       Impact factor: 28.547

View more
  52 in total

1.  p21CIP1 Promotes Mammary Cancer-Initiating Cells via Activation of Wnt/TCF1/CyclinD1 Signaling.

Authors:  Outhiriaradjou Benard; Xia Qian; Huizhi Liang; Zuen Ren; Kimita Suyama; Larry Norton; Rachel B Hazan
Journal:  Mol Cancer Res       Date:  2019-04-09       Impact factor: 5.852

Review 2.  Integrating single-cell RNA-sequencing and functional assays to decipher mammary cell states and lineage hierarchies.

Authors:  Joseph L Regan; Matthew J Smalley
Journal:  NPJ Breast Cancer       Date:  2020-07-29

3.  [Expression of transcription factor SOX12 in lung adenocarcinoma and its clinical significance].

Authors:  Li Li; Tingting Zhang; Yuhua Chen; Jia Song; Yao Meng; Shu Liu; Jianming Xie
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

Review 4.  Neural crest lineage analysis: from past to future trajectory.

Authors:  Weiyi Tang; Marianne E Bronner
Journal:  Development       Date:  2020-10-23       Impact factor: 6.868

5.  ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.

Authors:  Guotai Xu; Sagar Chhangawala; Emiliano Cocco; Pedram Razavi; Yanyan Cai; Jordan E Otto; Lorenzo Ferrando; Pier Selenica; Erik Ladewig; Carmen Chan; Arnaud Da Cruz Paula; Matthew Witkin; Yuanming Cheng; Jane Park; Cristian Serna-Tamayo; HuiYong Zhao; Fan Wu; Mirna Sallaku; Xuan Qu; Alison Zhao; Clayton K Collings; Andrew R D'Avino; Komal Jhaveri; Richard Koche; Ross L Levine; Jorge S Reis-Filho; Cigall Kadoch; Maurizio Scaltriti; Christina S Leslie; José Baselga; Eneda Toska
Journal:  Nat Genet       Date:  2020-01-13       Impact factor: 38.330

6.  Embryonic Barcoding of Equipotent Mammary Progenitors Functionally Identifies Breast Cancer Drivers.

Authors:  Zhe Ying; Slobodan Beronja
Journal:  Cell Stem Cell       Date:  2020-02-13       Impact factor: 24.633

Review 7.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

8.  The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells.

Authors:  Igor L Bado; Weijie Zhang; Jingyuan Hu; Zhan Xu; Hai Wang; Poonam Sarkar; Lucian Li; Ying-Wooi Wan; Jun Liu; William Wu; Hin Ching Lo; Ik Sun Kim; Swarnima Singh; Mahnaz Janghorban; Aaron M Muscarella; Amit Goldstein; Purba Singh; Hyun-Hwan Jeong; Chaozhong Liu; Rachel Schiff; Shixia Huang; Matthew J Ellis; M Waleed Gaber; Zbigniew Gugala; Zhandong Liu; Xiang H-F Zhang
Journal:  Dev Cell       Date:  2021-04-19       Impact factor: 12.270

9.  CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.

Authors:  April C Watt; Paloma Cejas; Molly J DeCristo; Otto Metzger-Filho; Enid Y N Lam; Xintao Qiu; Haley BrinJones; Nikolas Kesten; Rhiannon Coulson; Alba Font-Tello; Klothilda Lim; Raga Vadhi; Veerle W Daniels; Joan Montero; Len Taing; Clifford A Meyer; Omer Gilan; Charles C Bell; Keegan D Korthauer; Claudia Giambartolomei; Bogdan Pasaniuc; Ji-Heui Seo; Matthew L Freedman; Cynthia Ma; Matthew J Ellis; Ian Krop; Eric Winer; Anthony Letai; Myles Brown; Mark A Dawson; Henry W Long; Jean J Zhao; Shom Goel
Journal:  Nat Cancer       Date:  2020-11-09

10.  A new view of the mammary epithelial hierarchy and its implications for breast cancer initiation and metastasis.

Authors:  Lindsey J Anstine; Ruth Keri
Journal:  J Cancer Metastasis Treat       Date:  2019-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.